Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men.
Subst Abuse Treat Prev Policy. 2023 Nov 11;18(1):66. doi: 10.1186/s13011-023-00573-8.
Subst Abuse Treat Prev Policy. 2023.
PMID: 37951896
Free PMC article.
Oncoxin-Viusid® may improve quality of life and survival in patients with hormone-refractory prostate cancer undergoing onco-specific treatments.
Fundora Ramos MI, Maden LB, Casanova FO, Cruz FH, Reyes CS, Gato AH, Lyncon IB, González EV, Morales KP, Lence JJ, Sanz E.
Fundora Ramos MI, et al. Among authors: maden lb.
Mol Clin Oncol. 2021 Jan;14(1):5. doi: 10.3892/mco.2020.2167. Epub 2020 Nov 5.
Mol Clin Oncol. 2021.
PMID: 33235733
Free PMC article.
Item in Clipboard
Cite
Cite